Skip to content

Clinical trials

Phase 3 Tetanus trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tetanus Phase: Phase 3 Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20074
20081
20091
20102
20111
20131
20212
20221
20232
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting3
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline8
CanSino Biologics Inc.3
Sanofi2
Sinovac Life Sciences Co., Ltd.2
Beijing Minhai Biotechnology Co., Ltd1
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd1
China National Biotec Group Company Limited1
Genrix (Shanghai) Biopharmaceutical Co., Ltd.1
Sanofi Pasteur, a Sanofi Company1
Zhuhai Trinomab Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tetanus21
Diphtheria15
Haemophilus Infections6
Whooping Cough4
Poliomyelitis3
Pneumococcal Infections1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.